Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xing Zhang, Lingyun Bi, Yu Ye & Jian Chen. (2014) Formononetin Induces Apoptosis in PC-3 Prostate Cancer Cells Through Enhancing the Bax/Bcl-2 Ratios and Regulating the p38/Akt Pathway. Nutrition and Cancer 66:4, pages 656-661.
Read now
Read now
Articles from other publishers (21)
Max Christenson, Chung-Seog Song, Ya-Guang Liu & Bandana Chatterjee. (2022) Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy. Cancers 14:4, pages 892.
Crossref
Crossref
Konstantin Horas & Markus J. Seibel. 2022. Bone Cancer. Bone Cancer
413
429
.
Bradley M. Turner & David G. Hicks. 2022. Bone Cancer. Bone Cancer
771
782
.
Oliver Trusler, Jacob Goodwin & Andrew L. Laslett. (2021) BRCA1 and BRCA2 associated breast cancer and the roles of current modelling systems in drug discovery. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188459.
Crossref
Crossref
Gary Gustavsen, Kelsey Taylor, Doria Cole, Laura Gullet & Nicolas Lewine. (2020) Health economic impact of a biopsy-based cell cycle gene expression assay in localized prostate cancer. Future Oncology 16:36, pages 3061-3074.
Crossref
Crossref
Eric Ballon-Landa, Justine Panian, Ithaar H. Derweesh & Rana R. McKay. (2020) Management of bone complications in patients with genitourinary malignancies. Urologic Oncology: Seminars and Original Investigations 38:3, pages 94-104.
Crossref
Crossref
Gary Gustavsen, Laura Gullet, Doria Cole, Nicolas Lewine & Jay T Bishoff. (2020) Economic burden of illness associated with localized prostate cancer in the United States. Future Oncology 16:1, pages 4265-4277.
Crossref
Crossref
Sun H. Park, Evan T. Keller & Yusuke Shiozawa. (2017) Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. Calcified Tissue International 102:2, pages 152-162.
Crossref
Crossref
Ping Tang & David G. Hicks. 2015. Bone Cancer. Bone Cancer
461
470
.
Markus J. Seibel. 2015. Bone Cancer. Bone Cancer
123
138
.
Maha Hussain, Paul G. Corn, M. Dror Michaelson, Hans J. Hammers, Joshi J. Alumkal, Charles J. Ryan, Justine Y. Bruce, Susan Moran, Shih-Yuan Lee, H. Mark Lin & Daniel J. George. (2014) Phase II Study of Single-Agent Orteronel (TAK-700) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer and Rising Prostate-Specific Antigen. Clinical Cancer Research 20:16, pages 4218-4227.
Crossref
Crossref
Candice Yong, Eberechukwu Onukwugha & C. Daniel Mullins. (2014) Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer. Current Opinion in Oncology 26:3, pages 274-283.
Crossref
Crossref
Wei-Xiang Qi, Li-Na Tang, Ai-Na He, Yang Yao & Zan Shen. (2013) Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials. International Journal of Clinical Oncology 19:2, pages 403-410.
Crossref
Crossref
Zanjing Zhai, Xinhua Qu, Wei Yan, Haowei Li, Guangwang Liu, Xuqiang Liu, Tingting Tang, An Qin & Kerong Dai. (2014) Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling. Breast Cancer Research and Treatment 144:1, pages 33-45.
Crossref
Crossref
Shahrzad Rafiei & Svetlana V Komarova. (2013) Molecular Signaling Pathways Mediating Osteoclastogenesis Induced by Prostate Cancer Cells. BMC Cancer 13:1.
Crossref
Crossref
Akiko KukitaToshio Kukita. (2013) Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis. Future Oncology 9:11, pages 1609-1622.
Crossref
Crossref
Cheng Yang, Gui-Sheng Qi, Rui-Ming Rong & Jian He. (2013) Clinical features and treatment strategies for older prostate cancer patients with bone metastasis. Asian Journal of Andrology 15:6, pages 759-763.
Crossref
Crossref
Isla P. Garraway. (2013) Targeting the RANKL Pathway: Putting the Brakes on Prostate Cancer Progression in Bone. Journal of Clinical Oncology 31:30, pages 3838-3840.
Crossref
Crossref
LIN XU, ZHU WANG, XIAO-FEI LI, XIA HE, LIN-LIN GUAN, JIU-LING TUO, YANG WANG, YANFEN LUO, HUI-LING ZHONG, SHAO-PENG QIU & KAI-YUAN CAO. (2013) Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis. Oncology Reports 30:4, pages 1920-1928.
Crossref
Crossref
C. Monneret. (2013) Actualités thérapeutiques : l’abiratérone, le bélatacept, le vandétanib et la fidaxomycine. Annales Pharmaceutiques Françaises 71:2, pages 95-103.
Crossref
Crossref
Sathana DushyanthenDavina A.F. CossignyGerald M.Y. Quan. (2013) The Osteoblastic and Osteoclastic Interactions in Spinal Metastases Secondary to Prostate Cancer. Cancer Growth and Metastasis 6, pages CGM.S12769.
Crossref
Crossref